Sana Biotechnology (SANA) Financials

$2.92

$-0.24 (-7.59%)

As on 16-Sep-2026 16:10EDT

Market cap

$937 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	5.44	12.75	15.49	30.87	27.73	17.91
Gross Profit	-5.44	-12.75	-15.49	-30.87	-27.73	-17.91
Operating Expenses	205.61	178.21	272.72	293.14	272.56	356.91
Operating Profit (EBIT)	-208.00	-190.96	-272.72	-293.14	-272.56	-356.91
Other Income	--	--	--	--	-0.67	0.31
Profit before Tax	-211.82	-244.17	-266.76	-283.26	-269.48	-355.93
Provision for Tax	--	--	--	--	-3.09	-11.75
Profit after Tax (Net Income)	-211.82	-244.17	-266.76	-283.26	-266.39	-344.18
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-269.48	-355.93

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	154.57	160.88	250.50	287.51	499.32	728.50
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	153.20	177.28	205.08	213.31	211.90	301.67
Current Liabilities	123.75	78.73	45.43	64.49	111.50	99.24
Total Liabilities	555.27	416.89	501.02	565.30	822.72	1,129.41

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	260.89	268.21	340.21	351.78	378.28	571.31
Current Assets	170.63	148.68	160.81	213.52	444.44	558.10
Total Assets	555.27	416.89	501.02	565.30	822.72	1,129.41
Total Debt*	73.74	78.86	94.20	104.10	108.25	110.94
Net Current Assets	46.88	69.95	115.38	149.03	332.93	458.87

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-143.83	-223.15	-253.58	-290.05	-251.05
Cash Flow from Investing Activities	--	-40.24	17.45	172.01	210.56	-245.80
Cash from Financing Activities	--	128.73	199.75	31.65	4.91	631.75
Net Cash Inflow / Outflow	--	--	--	--	-74.58	134.90

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.78	-0.96	-1.13	-1.44	-1.40	-1.87
Cash EPS ($)	--	-0.91	-1.06	-1.31	-1.32	-1.81
Adjusted Book Value ($)	--	0.64	1.06	1.46	2.62	3.96
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.57	-0.94	-1.29	-1.52	-1.36
Free Cash Flow per Share ($)	--	-0.57	-1.09	-1.39	-1.63	-1.53

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-83.55	-72.46	-56.70	-36.82	-140.43
ROE (%)	-134.30	-118.70	-99.17	-72.00	-43.39	-223.99
ROA (%)	-44.58	-53.20	-50.03	-40.81	-27.29	-37.01
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	39,523.44	-112,846.56
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-1.47	8.47	5.82	-3.92	23.63	-24.73
Net Profit Growth (%)	16.00	8.47	5.82	-6.33	22.60	-23.52
EPS Growth (%)	26.67	0.15	0.21	-0.03	0.25	-0.18
Book Value Growth (%)	1.70	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-4.22	-1.44	-2.84	-2.82	-8.28
Price / Book Value	5.98	6.41	1.54	2.80	1.51	3.91
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.08	-4.20	-1.31	-2.72	-1.70	-6.96
Close Price ($)	3.49	4.07	1.63	4.08	3.95	15.48
High Price ($)	6.55	7.30	12.00	8.01	16.29	44.60
Low Price ($)	2.60	1.26	1.52	2.75	3.15	14.90
Market Cap ($ Cr)	937.00	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.49	0.38	0.36	0.22	0.15
Short term debt to equity ratio	0.09	0.09	0.05	0.05	0.02	0.01
Current Ratio	1.38	1.89	3.54	3.31	3.99	5.62
Quick Ratio	1.38	--	--	--	--	--
Interest Coverage	--	--	--	--	-17.44	-32.24

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	98.53	109.85	41.21	33.43	45.59
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.